QIAGEN launches QIAprep& Plasmodium Kit to strengthen malaria research and surveillance efforts
QIAGEN N.V. announced the launch of the QIAprep& Plasmodium Kit and two companion assays to support malaria research and surveillance efforts.
This new solution combines sample preparation and quantitative PCR (qPCR) into a single workflow, providing a rapid and accessible tool for detecting malaria-causing parasites from blood samples.
The QIAprep& Plasmodium Kit simplifies malaria research by enabling the detection of all five Plasmodium species in human samples.
QIAGEN’s QIAprep& technology – originally developed for COVID-19 research – integrates liquid-based sample preparation with qPCR into a streamlined and cost-efficient workflow. It offers high sensitivity, detecting as little as one parasite per microliter, and is compatible with both liquid and dried blood samples, including QIAcard FTA cards. It is also suitable for use on many qPCR platforms, including QIAGEN’s Rotor-Gene Q.
The accompanying assays further enhance malaria research detection and differentiation. The QIAGEN Pf/Non-Pf Detection Assay is a single-reaction screen for the most common cause of malaria in humans involving Plasmodium falciparum, while the QIAGEN Pv/Pm/Po/Pk Detection Assay helps distinguish between the remaining four common species that cause malaria – P. vivax, P. malariae, P. ovale, and P. knowlesi – allowing scientists to track mixed infections, study parasite evolution during vaccine rollouts and ensure that comprehensive epidemiological surveillance data is available when designing response measures.
For more information about the QIAprep& Plasmodium Kit and assays, visit:
https://www.qiagen.com/de/products/discovery-and-translational-research/pcr-qpcr-dpcr/real-time-pcr-enzymes-and-kits/qiaprep-and-amp-plasmodium-kit
